RT Journal Article
SR Electronic
T1 Normalisation of SARS-CoV-2 concentrations in wastewater: the use of flow, conductivity and CrAssphage
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.30.21266889
DO 10.1101/2021.11.30.21266889
A1 Langeveld, Jeroen
A1 Schilperoort, Remy
A1 Heijnen, Leo
A1 Elsinga, Goffe
A1 Schapendonk, Claudia E.M.
A1 Fanoy, Ewout
A1 de Schepper, Evelien I.T.
A1 Koopmans, Marion P. G.
A1 de Graaf, Miranda
A1 Medema, Gertjan
YR 2021
UL http://medrxiv.org/content/early/2021/11/30/2021.11.30.21266889.abstract
AB Over the course of the COVID-19 pandemic in 2020-2021, monitoring of SARS-CoV-2 RNA in wastewater has rapidly evolved into a supplementary surveillance instrument for public health. Short term trends (2 weeks) are used as a basis for policy and decision making on measures for dealing with the pandemic. Normalization is required to account for the varying dilution rates of the domestic wastewater, that contains the shedded virus RNA. The dilution rate varies due to runoff, industrial discharges and extraneous waters. Three normalization methods using flow, conductivity and CrAssphage, have been investigated on 9 monitoring locations between Sep 2020 and Aug 2021, rendering 1071 24-hour flow-proportional samples. In addition, 221 stool samples have been analyzed to determine the daily CrAssphage load per person. Results show that flow normalization supported by a quality check using conductivity monitoring is the advocated normalization method in case flow monitoring is or can be made available. Although Crassphage shedding rates per person vary greatly, the CrAssphage loads were very consistent over time and space and direct CrAssphage based normalization can be applied reliably for populations of 5600 and above.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSTOWA, TKI Water Technology in collaboration with Erasmus Foundation, Adessium Foundation, European Union Horizon H2020 grant VEO (grant no. 874735), Ministry of Health, Welfare and Sport, H2020 and Waterboards Waterschap Hollandse Delta, Hoogheemraadschap van Delfland and Hoogheemraadschap Schieland en KrimpenerwaardAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Medical Ethical Committee of Erasmus MC under MEC-2020-0617I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the figures of the manuscript